Altanine Names Charles J. Andres, Ph.D., J.D., as CEO to Lead Clinical and Strategic ExpansionLOS ANGELES, July 29, 2025 (GLOBE NEWSWIRE) -- Altanine, Inc., a pharmaceutical company advancing proprietary drug delivery technologies across high-growth therapeutic areas, today announced the appointment of Charles J. Andres, Ph.D., J.D., as its new Chief Executive Officer.
